Tianeptine, originally developed as the mood-boosting drug in Europe , has sparked considerable controversy internationally. Unlike most antidepressants which act by increasing serotonin levels, tianeptine seems to improve serotonin transport and affects glutamate , leading atypical effects . Its availability on the copyright, often without regulat